Cyclosporine (CsA)
Sponsors
Bristol-Myers Squibb, Assistance Publique - Hôpitaux de Paris, shifeng Lou, University of California, San Francisco, Peking Union Medical College Hospital
Conditions
Chronic Kidney FailureGraft Versus Host DiseaseHematopoietic Stem Cell TransplantationHemophagocytic SyndromeKidney TransplantationSevere Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic AnemiaTraumatic Brain Injury
Phase 2
Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation
CompletedNCT00948727
Start: 2004-01-31End: 2008-06-30Updated: 2009-10-01
TRACK-TBI Precision Medicine Part 3 - Option II
Enrolling by invitationNCT06790095
Start: 2026-06-01End: 2027-05-01Target: 26Updated: 2026-05-12
CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA
Not yet recruitingNCT07523009
Start: 2026-04-01End: 2029-12-01Target: 43Updated: 2026-04-13
CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA
Not yet recruitingNCT07558434
Start: 2026-04-01End: 2029-12-01Target: 43Updated: 2026-04-30
Phase 3
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
CompletedNCT00256750
Start: 2005-03-31End: 2015-04-30Updated: 2016-08-19
Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA
Not yet recruitingNCT07548671
Start: 2026-04-01End: 2029-12-01Target: 90Updated: 2026-04-23